Cancer Cells Increase DNA Mutations to Evade Treatment
Cancer Cells Increase DNA Mutations to Evade Treatment
Colorectal tumor cells limit their DNA repair in response to a targeted therapy, giving them a greater chance to develop resistance to the drug.
Cancer Cells Increase DNA Mutations to Evade Treatment
Cancer Cells Increase DNA Mutations to Evade Treatment

Colorectal tumor cells limit their DNA repair in response to a targeted therapy, giving them a greater chance to develop resistance to the drug.

Colorectal tumor cells limit their DNA repair in response to a targeted therapy, giving them a greater chance to develop resistance to the drug.

drug resistance
First New Tuberculosis Drug Approved in 50 Years
First New Tuberculosis Drug Approved in 50 Years
Jef Akst | Aug 15, 2019
The US Food and Drug Administration green lights a therapy for an extreme form of multidrug resistant TB.
FDA Suspends Clinical Trials Involving Fecal Transplants
FDA Suspends Clinical Trials Involving Fecal Transplants
Chia-Yi Hou | Jun 14, 2019
The agency issued a safety warning after two patients contracted antibiotic-resistant infections and one of the patients died.
Q&amp;A: What to Know About the Drug-Resistant Fungus, <em>Candida auris</em>
Q&A: What to Know About the Drug-Resistant Fungus, Candida auris
Emma Yasinski | Apr 18, 2019
Fungal researcher Christina Cuomo discusses the spread of infections plaguing hospitals across the world.
Infographic: Fighting Malaria Drug Resistance
Infographic: Fighting Malaria Drug Resistance
Natalie Slivinski | Mar 1, 2019
The parasite that causes malaria has evolved to evade many of the drugs that researchers have developed to fight the tropical disease.
Are We Headed for a New Era of Malaria Drug Resistance?
Are We Headed for a New Era of Malaria Drug Resistance?
Natalie Slivinski | Mar 1, 2019
Plasmodium falciparum has shown an ability to evade everything we throw at it, most recently artemisinin-based combination therapies, today’s front-line treatment.
Image of the Day: Tumor Organoids
Image of the Day: Tumor Organoids
The Scientist Staff, The Scientist Staff | Apr 11, 2018
Miniature versions of bladder cancers could help physicians identify personalized treatment options for patients.
Mutant RAS Proteins Team Up for Oncogenicity
Mutant RAS Proteins Team Up for Oncogenicity
Jim Daley | Apr 1, 2018
Mice with cancer whose KRAS proteins couldn’t link together had much better survival outcomes than those whose oncogenic mutant paired with wild-type KRAS.
New Class of Drugs Kills MRSA in Mice
New Class of Drugs Kills MRSA in Mice
Jim Daley | Mar 28, 2018
Researchers find two new antibiotics that offer promise in the fight against drug-resistant bacteria.  
Many Non-Antibiotic Drugs Affect Gut Bacteria
Many Non-Antibiotic Drugs Affect Gut Bacteria
Catherine Offord | Mar 20, 2018
A new study finds that more than 200 human-targeted, non-antibiotic drugs inhibit the growth of bacterial species that make up part of the human microbiome.